Aurora Selected to Supply Medical Cannabis in Italy

The Italian government has selected Aurora Cannabis (NYSE: ACB) (TSX: ACB) in a bidding process to supply medical cannabis in Italy.

Story continues below

Aurora is the only winner of the Italian government’s public tender for the supply of medical cannabis. The tender saw five companies participate, with Aurora selected as the sole winner of three lots to supply the Italian market, which is one of the most strictly regulated medical cannabis markets in the world.

The supply contract is expected to be signed in September.

For the second time, Aurora won a tender for the supply of medical cannabis to the Italian market. The company won the first tender in January 2018.

Aurora will supply a minimum of 400 kg of medical cannabis over the two-year contract with the cannabis coming from its Canadian EU GMP certified facilities and imported to Italy through its European subsidiary Aurora Deutschland.

The cannabis will be sold to Agenzia Industrie Difesa, an agency of the Italian Ministry of Defense, for distribution to local pharmacies, who dispense directly to patients.

“We want to continue to build our connection with patients and pharmacies in the Italian market, who have come to know and appreciate our products over most of the past two years. I’m extremely proud of our team. This win reflects our ability to navigate complex international regulations and work with governments around the world to establish ourselves as a trusted partner,” stated Neil Belot, chief global business development officer at Aurora.

An ad to help with our costs